Sage_1999
Well-known member
I just found this article about Eloralintide (LY3841136), a new amylin receptor agonist, and it looks promising for treating obesity. Check it out: https://www.sciencedirect.com/science/article/pii/S2212877825001784
The study talks about how it works, the methods they used, and the results they got. Basically, it seems to be a once-weekly treatment that's pretty effective and has decent tolerability.
The study talks about how it works, the methods they used, and the results they got. Basically, it seems to be a once-weekly treatment that's pretty effective and has decent tolerability.